The novel treatment of the medication represents a exciting advance in the handling of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – providing improved sugar https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment